The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Glossary Glossary

Complera (Rilpivirine/Tenofovir/FTC)

The Details

Complera (rilpivirine/tenofovir/emtricitabine) is a multi-class combination drug used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in adults with an HIV viral load less than or equal to 100,000 copies/mL. It is listed in the HHS HIV treatment guidelines as an alternative regimen for people starting HIV treatment for the first time.


Adult single dose: Take one tablet once daily. Each tablet contains 200 mg of emtricitabine, 25 mg of rilpivirine, and 300 mg of tenofovir disoproxil fumarate.


  • Take with food.
  • Complera should not be taken in combination with other anti-HIV medicines.
  • Women should not breastfeed while on Complera.
The Basics
News & Research

  • Email Email
  • Glossary Glossary

The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.